搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
eypt
/
财务摘要
EyePoint Pharmaceuticals Inc
EYPT
添加自选
4.250
USD
+0.020
+0.47%
收盘 09-11 16:00(美东)
361.17M
总市值
亏损
市盈率 TTM
EyePoint Pharmaceuticals Inc
4.250
+0.020
+0.47%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
EYPT 财务数据
通过专为投资者打造的一站式数据看板,全面查看 EyePoint Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
361.17M
股息TTM
0.00
市盈率 TTM
-1.21
每股收益TTM
-3.51
营业收入
31.37M
净利润
-130.87M
净资产收益率
-102.71%
总资产收益率
-83.47%
EyePoint Pharmaceuticals Inc 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
-1.09
/-0.95
营业收入 / 预测值
507.00K
/406.86K
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-28.45%
-1.09
-52.27%
-0.99
-26.92%
-0.81
-57.86%
-0.85
-46.68%
-0.85
-17.05%
-0.65
-91.79%
-0.64
-63.93%
-0.54
5.02%
-0.58
1.97%
-0.55
71.28%
-0.33
--
-0.33
--
-0.61
--
-0.56
--
-1.16
--
-1.58
--
--
--
--
--
--
--
--
营业收入
-90.49%
507.00K
-97.15%
696.00K
-94.65%
620.00K
-90.82%
966.00K
-43.73%
5.33M
109.29%
24.45M
-17.39%
11.59M
-30.77%
10.52M
4.09%
9.48M
52.08%
11.68M
33.18%
14.03M
51.84%
15.20M
-21.27%
9.11M
-17.33%
7.68M
-8.76%
10.53M
10.52%
10.01M
28.31%
11.56M
26.92%
9.29M
61.88%
11.54M
-42.28%
9.06M
净利润
-58.97%
-94.47M
-87.70%
-84.83M
-63.31%
-67.61M
-103.44%
-59.73M
-92.78%
-59.43M
-54.33%
-45.20M
-193.63%
-41.40M
-132.80%
-29.36M
-34.49%
-30.83M
-38.37%
-29.28M
67.55%
-14.10M
31.53%
-12.61M
-18.11%
-22.92M
-0.90%
-21.16M
-123.61%
-43.45M
-10.33%
-18.42M
-93.87%
-19.41M
-70.81%
-20.98M
-25.62%
-19.43M
-339.23%
-16.70M
利润率
-1572.17%
-18633.14%
-6494.66%
-12188.51%
-2952.33%
-10904.68%
-2116.36%
-6183.44%
-242.58%
-1114.31%
26.26%
-184.82%
-255.46%
-357.26%
-236.28%
-278.99%
-29.21%
-325.27%
9.01%
-250.63%
75.64%
-100.51%
--
-82.96%
--
-251.73%
--
-275.47%
--
-412.53%
--
-190.48%
--
--
--
--
--
--
--
--
毛利率
3.19%
100.00%
-75.04%
24.14%
-57.49%
39.52%
-72.73%
25.36%
13.72%
96.91%
3.43%
96.71%
0.08%
92.96%
0.99%
93.01%
6.10%
85.22%
2.00%
93.50%
41.42%
92.89%
--
92.09%
--
80.32%
--
91.67%
--
65.68%
--
78.10%
--
--
--
--
--
--
--
--
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00%
--
0.00%
--
0.00%
--
22.42%
--
22.08%
--
18.05%
--
--
--
--
--
--
--
--
利润表
营业收入
-90.49%
507.00K
-97.15%
696.00K
-94.65%
620.00K
-90.82%
966.00K
-43.73%
5.33M
109.29%
24.45M
-17.39%
11.59M
-30.77%
10.52M
4.09%
9.48M
52.08%
11.68M
33.18%
14.03M
51.84%
15.20M
-21.27%
9.11M
-17.33%
7.68M
-8.76%
10.53M
10.52%
10.01M
28.31%
11.56M
26.92%
9.29M
61.88%
11.54M
-42.28%
9.06M
营业利润
-56.49%
-97.38M
-78.61%
-87.23M
-55.50%
-70.34M
-89.40%
-62.02M
-80.13%
-62.23M
-46.57%
-48.84M
-176.62%
-45.24M
-127.45%
-32.75M
-51.78%
-34.55M
-54.59%
-33.32M
29.01%
-16.35M
21.74%
-14.40M
-18.45%
-22.76M
-17.88%
-21.55M
-27.62%
-23.04M
-20.15%
-18.40M
-75.03%
-19.22M
-67.21%
-18.28M
-41.71%
-18.05M
-682.47%
-15.31M
净利润
-58.97%
-94.47M
-87.70%
-84.83M
-63.31%
-67.61M
-103.44%
-59.73M
-92.78%
-59.43M
-54.33%
-45.20M
-193.63%
-41.40M
-132.80%
-29.36M
-34.49%
-30.83M
-38.37%
-29.28M
67.55%
-14.10M
31.53%
-12.61M
-18.11%
-22.92M
-0.90%
-21.16M
-123.61%
-43.45M
-10.33%
-18.42M
-93.87%
-19.41M
-70.81%
-20.98M
-25.62%
-19.43M
-339.23%
-16.70M
资产负债表
流动资产
-28.82%
188.82M
-23.70%
249.50M
-14.26%
328.65M
-19.53%
216.11M
-10.06%
265.25M
2.92%
326.98M
11.17%
383.31M
78.84%
268.55M
76.48%
294.93M
117.52%
317.71M
99.53%
344.80M
-21.83%
150.16M
-18.82%
167.12M
-33.50%
146.06M
-27.31%
172.81M
35.50%
192.10M
35.59%
205.87M
37.83%
219.63M
276.67%
237.75M
197.90%
141.78M
流动负债总额
26.43%
41.94M
-10.12%
37.46M
-24.51%
37.02M
-38.32%
30.09M
-46.58%
33.17M
-33.40%
41.68M
-22.47%
49.05M
-23.64%
48.79M
-9.89%
62.10M
129.72%
62.58M
83.17%
63.26M
86.52%
63.90M
106.40%
68.92M
-14.79%
27.24M
45.98%
34.54M
71.86%
34.26M
105.48%
33.39M
137.86%
31.97M
58.91%
23.66M
54.20%
19.93M
总资产
-24.23%
228.19M
-20.51%
288.22M
-13.02%
364.00M
-16.36%
251.69M
-7.12%
301.15M
10.12%
362.56M
17.82%
418.46M
88.02%
300.92M
84.59%
324.25M
112.98%
329.25M
96.93%
355.18M
-27.41%
160.04M
-24.75%
175.66M
-36.79%
154.59M
-31.52%
180.36M
31.05%
220.49M
30.54%
233.43M
30.68%
244.56M
187.16%
263.37M
119.10%
168.25M
总负债
12.05%
61.78M
-10.01%
57.74M
-29.38%
57.88M
-37.32%
51.51M
-42.53%
55.14M
-19.10%
64.17M
-7.76%
81.96M
-18.97%
82.18M
-18.96%
95.94M
4.08%
79.31M
5.80%
88.86M
20.54%
101.42M
44.26%
118.39M
-1.97%
76.20M
6.32%
83.99M
11.44%
84.14M
14.05%
82.07M
8.82%
77.74M
7.95%
78.99M
9.11%
75.50M
总权益
-32.36%
166.41M
-22.76%
230.47M
-9.03%
306.11M
-8.48%
200.18M
7.75%
246.01M
19.39%
298.40M
26.35%
336.50M
273.13%
218.73M
298.70%
228.31M
218.83%
249.93M
176.36%
266.32M
-57.01%
58.62M
-62.17%
57.26M
-53.01%
78.39M
-47.73%
96.37M
47.01%
136.35M
41.64%
151.37M
44.17%
166.82M
894.44%
184.38M
1121.33%
92.75M
现金流量表
经营净额
0.39%
-62.35M
-51.64%
-80.55M
-81.45%
-65.05M
-52.08%
-59.35M
-210.18%
-62.59M
-70.41%
-53.12M
-55.13%
-35.85M
-156.70%
-39.03M
-135.39%
-20.18M
-85.16%
-31.17M
-83.58%
-23.11M
-15.74%
-15.20M
398.19%
57.02M
16.48%
-16.84M
24.48%
-12.59M
-68.69%
-13.14M
-81.38%
-19.12M
-33.51%
-20.16M
-382.75%
-16.67M
-785.48%
-7.79M
投资净额
55.37%
75.10M
49.41%
59.05M
22.19%
-74.67M
241.97%
55.38M
130.14%
48.34M
89.97%
39.52M
-103.53%
-95.96M
1041.63%
16.20M
-1291.02%
-160.40M
-35.16%
20.81M
-243.23%
-47.15M
-127.42%
-1.72M
112325.00%
13.47M
156.85%
32.09M
199.85%
32.92M
4887.79%
6.27M
52.00%
-12.00K
--
-56.44M
-17069.27%
-32.97M
-2.34%
-131.00K
融资净额
8300.00%
19.99M
-174.87%
-2.61M
10.07%
166.96M
-37.75%
7.40M
-27.66%
238.00K
-926.96%
-951.00K
-30.57%
151.69M
14.78%
11.89M
100.90%
329.00K
102.25%
115.00K
376798.28%
218.49M
11163.04%
10.36M
-13181.88%
-36.66M
-1042.63%
-5.12M
-100.05%
-58.00K
4700.00%
92.00K
27.56%
-276.00K
-100.41%
-448.00K
935.46%
108.52M
-100.04%
-2.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
EyePoint Pharmaceuticals Inc的总收入是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,总收入达到了31.37M(同比变化43.27M)。
EyePoint Pharmaceuticals Inc的流动资产是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,流动资产为328.65M(同比变化-14.26)。
EyePoint Pharmaceuticals Inc的总资产是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的总资产为364.00M(同比变化-13.02)。
EyePoint Pharmaceuticals Inc的总负债是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的总负债为57.88M(同比变化-29.38)。
EyePoint Pharmaceuticals Inc的总权益是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的总权益为306.11M(同比变化-9.03)。
EyePoint Pharmaceuticals Inc的净营业收入是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的净营业收入为-243.43M(同比变化-66.90)。
EyePoint Pharmaceuticals Inc的净投资是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的净投资为68.58M(同比变化131.26)。
EyePoint Pharmaceuticals Inc的净融资是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,EyePoint Pharmaceuticals Inc的净融资为173.65M(同比变化5.87)。
EyePoint Pharmaceuticals Inc的每股收益(EPS)是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-3.17(同比变化-36.22)。
EyePoint Pharmaceuticals Inc的净利润是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,净利润为-231.96M(同比变化-77.25)。
EyePoint Pharmaceuticals Inc的净利润率是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,净利润率为-739.42(同比变化-144.49)。
EyePoint Pharmaceuticals Inc的毛利率是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,毛利率为93.41(同比变化2.18)。
EyePoint Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-72.19(同比变化-66.27)。
EyePoint Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-59.29(同比变化-75.25)。
EyePoint Pharmaceuticals Inc的营业利润是多少?
根据EyePoint Pharmaceuticals Inc的FY2025财报,营业利润为-243.43M(同比变化-66.90)。